Kimberly Duff

3PUBLICATIONS
11CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 11, 2024
Long-term safety and tolerability of hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: Results from the ADVANCE-CIDP 3 trial.

Robert D M Hadden, Henning Andersen, Vera Bril

|Jun 19, 2024
Tolerability and Safety of Large-Volume Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% Administered with or without Dose Ramp-Up: A Phase 1 Study in Healthy Participants.

Zhaoyang Li, Andras Nagy, Dirk Lindner

|Dec 22, 2023
A Phase 1 Open-Label Study to Assess the Tolerability, Safety, and Immunogenicity of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 20% in Healthy Adults.

Andras Nagy, Kimberly Duff, Alexander Bauer

Pageof 1

Frequent Collaborators

2 joint publications

Zhaoyang Li

2 joint publications

Leman Yel

1 joint publications

Robert D M Hadden

1 joint publications

Henning Andersen